BRPI0412707A - partìculas contendo um agente ativo na forma de um coprecipitado - Google Patents
partìculas contendo um agente ativo na forma de um coprecipitadoInfo
- Publication number
- BRPI0412707A BRPI0412707A BRPI0412707-2A BRPI0412707A BRPI0412707A BR PI0412707 A BRPI0412707 A BR PI0412707A BR PI0412707 A BRPI0412707 A BR PI0412707A BR PI0412707 A BRPI0412707 A BR PI0412707A
- Authority
- BR
- Brazil
- Prior art keywords
- active agent
- coprecipitate
- particles containing
- particles
- precipitate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0308720A FR2857591B1 (fr) | 2003-07-17 | 2003-07-17 | Particules comprenant un principe actif sous forme de co-precipite |
PCT/FR2004/001878 WO2005009411A2 (fr) | 2003-07-17 | 2004-07-16 | Particules comprenant un principe actif sous forme de co-precipite |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0412707A true BRPI0412707A (pt) | 2006-09-26 |
BRPI0412707B1 BRPI0412707B1 (pt) | 2018-11-27 |
BRPI0412707B8 BRPI0412707B8 (pt) | 2021-05-25 |
Family
ID=33548203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0412707A BRPI0412707B8 (pt) | 2003-07-17 | 2004-07-16 | processo para preparo de partículas contendo itraconazol na forma de um co-precipitado e partículas |
Country Status (10)
Country | Link |
---|---|
US (2) | US20060222715A1 (pt) |
EP (1) | EP1651188B1 (pt) |
JP (1) | JP4754485B2 (pt) |
CN (1) | CN1822818B (pt) |
BR (1) | BRPI0412707B8 (pt) |
CA (1) | CA2532626C (pt) |
ES (1) | ES2544626T3 (pt) |
FR (1) | FR2857591B1 (pt) |
MX (1) | MXPA06000614A (pt) |
WO (1) | WO2005009411A2 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1279402B1 (en) * | 2001-07-26 | 2006-11-29 | Ethypharm | Coated granules of allylamine-or benzylamine-anti-mycotics, process for preparation thereof and orodispersible tablets containing said coated granules |
WO2012142084A1 (en) | 2011-04-11 | 2012-10-18 | ADA-ES, Inc. | Fluidized bed method and system for gas component capture |
AU2013317997B2 (en) | 2012-09-20 | 2016-04-07 | ADA-ES, Inc. | Method and system to reclaim functional sites on a sorbent contaminated by heat stable salts |
JP7048639B2 (ja) * | 2017-04-13 | 2022-04-05 | ザ プロクター アンド ギャンブル カンパニー | 離散粒子及び水性ベース組成物を含む製品組成物の調製方法 |
WO2023118082A1 (en) * | 2021-12-22 | 2023-06-29 | Palau Pharma, S.L.U. | Multiparticulate albaconazole composition |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4016254A (en) * | 1972-05-19 | 1977-04-05 | Beecham Group Limited | Pharmaceutical formulations |
JPS62221626A (ja) * | 1986-03-20 | 1987-09-29 | Tokyo Tanabe Co Ltd | 1,4−ジヒドロピリジン化合物の製剤用組成物 |
WO1994008709A1 (en) * | 1992-10-09 | 1994-04-28 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Production method for fine granulate |
JP3640980B2 (ja) * | 1993-04-09 | 2005-04-20 | 株式会社林原生物化学研究所 | ネコの呼吸器疾患治療剤とその治療剤を用いる治療方法 |
CA2240161C (en) * | 1996-05-20 | 2005-05-24 | Janssen Pharmaceutica N.V. | Antifungal compositions with improved bioavailability |
FR2758459B1 (fr) * | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
US6027747A (en) * | 1997-11-11 | 2000-02-22 | Terracol; Didier | Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions |
ES2157731B1 (es) * | 1998-07-21 | 2002-05-01 | Liconsa Liberacion Controlada | Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion. |
FR2803748A1 (fr) * | 2000-01-14 | 2001-07-20 | Ethypharm Lab Prod Ethiques | Composition d'itraconazole et procede de preparation |
GT200100039A (es) * | 2000-03-16 | 2001-12-31 | Pfizer | Inhibidor de la glucogeno fosforilasa. |
US6962908B2 (en) * | 2001-12-21 | 2005-11-08 | Warner Chilcott Company Inc. | Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
-
2003
- 2003-07-17 FR FR0308720A patent/FR2857591B1/fr not_active Expired - Lifetime
-
2004
- 2004-07-16 WO PCT/FR2004/001878 patent/WO2005009411A2/fr active Application Filing
- 2004-07-16 JP JP2006519969A patent/JP4754485B2/ja not_active Expired - Fee Related
- 2004-07-16 EP EP20040767702 patent/EP1651188B1/fr not_active Expired - Lifetime
- 2004-07-16 CN CN2004800205773A patent/CN1822818B/zh not_active Expired - Lifetime
- 2004-07-16 BR BRPI0412707A patent/BRPI0412707B8/pt not_active IP Right Cessation
- 2004-07-16 ES ES04767702.6T patent/ES2544626T3/es not_active Expired - Lifetime
- 2004-07-16 MX MXPA06000614A patent/MXPA06000614A/es active IP Right Grant
- 2004-07-16 US US10/564,786 patent/US20060222715A1/en not_active Abandoned
- 2004-07-16 CA CA2532626A patent/CA2532626C/fr not_active Expired - Lifetime
-
2010
- 2010-04-13 US US12/662,370 patent/US20100266702A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MXPA06000614A (es) | 2006-04-11 |
CA2532626C (fr) | 2013-03-26 |
CA2532626A1 (fr) | 2005-02-03 |
BRPI0412707B8 (pt) | 2021-05-25 |
EP1651188B1 (fr) | 2015-05-06 |
CN1822818A (zh) | 2006-08-23 |
BRPI0412707B1 (pt) | 2018-11-27 |
CN1822818B (zh) | 2012-07-25 |
EP1651188A2 (fr) | 2006-05-03 |
US20060222715A1 (en) | 2006-10-05 |
ES2544626T3 (es) | 2015-09-02 |
JP4754485B2 (ja) | 2011-08-24 |
US20100266702A1 (en) | 2010-10-21 |
WO2005009411A2 (fr) | 2005-02-03 |
FR2857591B1 (fr) | 2007-11-02 |
WO2005009411A3 (fr) | 2005-03-24 |
WO2005009411B1 (fr) | 2005-05-26 |
FR2857591A1 (fr) | 2005-01-21 |
JP2007528865A (ja) | 2007-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0409623A (pt) | produto farmacêutico, método de preparação do mesmo e uso de substáncias na preparação do referido produto farmacêutico | |
EG25011A (en) | Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments. | |
IL213597A0 (en) | Compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
IL226313A0 (en) | A method for producing gamma-carboxylated human prothrombin, isolated prothrombin produced by such a method, a pharmaceutical preparation including it and its use as drugs and for the production of drugs for the treatment of blood coagulation | |
HK1076095A1 (en) | Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same | |
CY1113116T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
ATE367152T1 (de) | Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung | |
ATE432710T1 (de) | Pharmazeutische zusammensetzungen, die diaminooxidase enthalten | |
HRP20070291T3 (en) | Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis | |
ATE417608T1 (de) | Arzneizusammensetzungen enthaltend modafinilverbindungen | |
PT1713438E (pt) | Sabonete medicinal | |
BRPI0611526A2 (pt) | composição tópica contendo gelatina | |
BRPI0412707A (pt) | partìculas contendo um agente ativo na forma de um coprecipitado | |
CA105215S (en) | Packaging with cosmetic composition | |
DE602004030015D1 (de) | Mischungen aus von heparin abgeleiteten oligosacchariden, herstellung davon und pharmazeutische zusammensetzungen, die die mischungen enthalten | |
BR0210632A (pt) | Tratamento de doença parasìtica | |
IL173918A0 (en) | Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same | |
MY130445A (en) | Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone | |
AU2003294952A8 (en) | 3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same | |
PL371518A1 (en) | Method for producing crystals from active ingredients in medicaments, crystals obtained therefrom and the use thereof in pharmaceutical formulations | |
AU2003246840A8 (en) | Anti-hiv composition, production method thereof and medicament | |
RU2001109481A (ru) | Антиангинальное средство | |
UA66456C2 (uk) | Лікарський засіб кардіологічної дії | |
ITAT20020014A1 (it) | Preparato cosmetico ad azione drenante e procedimenti per la fabbricazione, l'applicazione ed il confezionamento dello stesso. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/11/2018, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/07/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 19A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2731 DE 09-05-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |